Physician knowledge of a rare foot condition - influence of diabetic patient population on self-described knowledge and treatment
- PMID: 28702256
- PMCID: PMC5471700
- DOI: 10.1186/s40842-017-0041-4
Physician knowledge of a rare foot condition - influence of diabetic patient population on self-described knowledge and treatment
Abstract
Background: Charcot neuroarthopathy (CN), a rare foot and ankle condition usually complicating diabetes mellitus, leads to deformity, poor quality of life, and increased mortality and morbidity. The prevalence of this condition in the diabetic patient population is not currently known but has been reportedly misdiagnosed in up to 95% of cases.
Methods: We sought to evaluate general knowledge regarding CN in non-foot specialist clinical faculty at a large academic institution and to understand their practice habits. Our survey emphasizes the necessity of better education surrounding CN to improve outcomes in a preventative fashion. This will enable us to determine how to focus educational forums surrounding this topic in the future.
Results: Seven hundred eighty-nine faculty members were sent the survey while 400 completed the survey for a response rate of 50.7%. The respondents were representative of academic rank at the institution and were comprised of endocrinologists, internal medicine physicians and family medicine physicians. We found that 67.6% of responders had a self-described poor or complete lack of knowledge of this condition. Clinicians with self-described better knowledge of CN were more likely to provide a correct initial management of CN (p < 0.001; r = 0.3639).
Conclusions: In this large tertiary institution, a majority of providers among internal medicine, endocrinologists, and family medicine physicians demonstrated minimal or no knowledge of this rare, but potentially devastating diabetes complication. However, those providers who are knowledgeable of CN, performed better in the initial management of this condition. Also, respondents who treated more diabetic patients demonstrated an association with correct management. Education, and the development of better understanding amongst clinicians, is crucial to limit the devastating effects of this condition in the future.
Similar articles
-
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001. JBI Libr Syst Rev. 2009. PMID: 27819974
-
Clinical management of acute diabetic Charcot foot in Denmark.Dan Med J. 2016 Oct;63(10):A5273. Dan Med J. 2016. PMID: 27697131
-
Identification, evaluation, and management of obesity in an academic primary care center.Pediatrics. 2004 Aug;114(2):e154-9. doi: 10.1542/peds.114.2.e154. Pediatrics. 2004. PMID: 15286251
-
Management of Osteomyelitis and Bone Loss in the Diabetic Charcot Foot and Ankle.Clin Podiatr Med Surg. 2017 Jul;34(3):381-387. doi: 10.1016/j.cpm.2017.02.008. Epub 2017 Mar 22. Clin Podiatr Med Surg. 2017. PMID: 28576196 Review.
-
The Diabetic Charcot Foot from 1936 to 2016: Eighty Years Later and Still Growing.Clin Podiatr Med Surg. 2017 Jan;34(1):1-8. doi: 10.1016/j.cpm.2016.07.001. Epub 2016 Sep 3. Clin Podiatr Med Surg. 2017. PMID: 27865310 Review.
Cited by
-
Updates on Diabetic Foot and Charcot Osteopathic Arthropathy.Curr Diab Rep. 2018 Aug 15;18(10):74. doi: 10.1007/s11892-018-1047-8. Curr Diab Rep. 2018. PMID: 30112582 Review.
-
Radiological Assessment of Charcot Neuro-Osteoarthropathy in Diabetic Foot: A Narrative Review.Diagnostics (Basel). 2025 Mar 19;15(6):767. doi: 10.3390/diagnostics15060767. Diagnostics (Basel). 2025. PMID: 40150109 Free PMC article. Review.
-
Factors impacting the evidence-based assessment, diagnosis and management of Acute Charcot Neuroarthropathy: a systematic review.J Foot Ankle Res. 2021 Apr 7;14(1):26. doi: 10.1186/s13047-021-00469-5. J Foot Ankle Res. 2021. PMID: 33827640 Free PMC article.
-
Review and Evaluation of European National Clinical Practice Guidelines for the Treatment and Management of Active Charcot Neuro-Osteoarthropathy in Diabetes Using the AGREE-II Tool Identifies an Absence of Evidence-Based Recommendations.J Diabetes Res. 2024 Jun 10;2024:7533891. doi: 10.1155/2024/7533891. eCollection 2024. J Diabetes Res. 2024. PMID: 38899148 Free PMC article. Review.
-
Charcot neuroarthropathy patient education among podiatrists in Scotland: a modified Delphi approach.J Foot Ankle Res. 2018 Sep 24;11:54. doi: 10.1186/s13047-018-0296-8. eCollection 2018. J Foot Ankle Res. 2018. PMID: 30258497 Free PMC article.
References
-
- NIDDK NIH Summary Report Charcot Workshop, co-sponsored by NIH’s Office of Rare Diseases (2008), http://archives.niddk.nih.gov/neuroarthropathy/SummaryReport.pdf,/neuroa...
-
- Lavery L, Armstrong D, Wunderlich R, Tredwell J, Boulton A. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26(5):1435–8. doi: 10.2337/diacare.26.5.1435. - DOI - PubMed
-
- O’Loughlin A, Kellegher E, McCusker C, Canavan R. Diabetic Charcot neuroarthropathy: prevalence, demographics and outcome in a regional referral centre. Ir J Med Sci. 2016 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources